Artwork

Player FM - Internet Radio Done Right
Checked 10M ago
Lagt til three år siden
Innhold levert av Zain Medical Center. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Zain Medical Center eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Player FM - Podcast-app
Gå frakoblet med Player FM -appen!
icon Daily Deals

Alzheimer's Disease Latest Research by Zain Medical

3:22
 
Del
 

Manage episode 311817203 series 3189124
Innhold levert av Zain Medical Center. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Zain Medical Center eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

Alzheimer's disease is a neurological dysfunction in which the death of brain cells prompts memory loss and cognitive deterioration said by the experts of Zain Medical Center. During the disease, the symptom may seem delicate but they can become more stringent over time. Recent studies have determined that more than 6.8 million people in the U.S. are surviving from this disease. And due to this, researchers have discovered a new drug research that may protect against memory loss in Alzheimer's disease.

Let's find out which type of drug research is this and how it will treat the disease with the experts of Zain Medical Center.

Drug Research on Alzheimer’s disease

After too much of study on drug research, researchers have been able to find the drug named BPN14770 that can defend against memory loss of Alzheimer's disease. This new drug hinders the impacts of amyloid-beta, a trademark proteid of Alzheimer's that is poisonous to nerve cells. Its benefits could also interpret to Fragile X syndrome says Sami Anwar the research director of Zain Medical Center.

Drug BPN14770

Also, investigations have indicated that Alzheimer's pathogeny can be endured by the brain to some measure due to compensatory mechanisms functioning at the cellular and synaptic levels said by the experts of Zain Medical Center. Researchers have also suggested that BPN14770 may be proficient in stimulating complicated physiological mechanisms. It preserve the cerebellum from memory shortfalls, neuronal impairment, and biochemical impairments.

When the drug BPN14770 was tested on mice it was found that it inhibited the action of phosphodiesterase 4D (PDE4D). It’s an enzyme that performs a pivotal character in consciousness, learning, neuroinflammation, and traumatic understanding hemorrhage. The enzyme named as PDE4D diminishes the cAMP - that has copious propitious roles, including enhanced retention. Also, cAMP acts as an intermediary particle that indicates physiological alterations. It includes cell division, transformation, movement and separation throughout the body, commencing to substantial modifications in the brain.

BPN14770 acts by an innovative mechanism to enhance cyclic AMP signalling in the brain, which has been shown to enhance memory. According to the experts of Zain Medical Center, the collaborative project has led to clinical trials that will begin to test its effectiveness.

  continue reading

13 episoder

Artwork
iconDel
 
Manage episode 311817203 series 3189124
Innhold levert av Zain Medical Center. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Zain Medical Center eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

Alzheimer's disease is a neurological dysfunction in which the death of brain cells prompts memory loss and cognitive deterioration said by the experts of Zain Medical Center. During the disease, the symptom may seem delicate but they can become more stringent over time. Recent studies have determined that more than 6.8 million people in the U.S. are surviving from this disease. And due to this, researchers have discovered a new drug research that may protect against memory loss in Alzheimer's disease.

Let's find out which type of drug research is this and how it will treat the disease with the experts of Zain Medical Center.

Drug Research on Alzheimer’s disease

After too much of study on drug research, researchers have been able to find the drug named BPN14770 that can defend against memory loss of Alzheimer's disease. This new drug hinders the impacts of amyloid-beta, a trademark proteid of Alzheimer's that is poisonous to nerve cells. Its benefits could also interpret to Fragile X syndrome says Sami Anwar the research director of Zain Medical Center.

Drug BPN14770

Also, investigations have indicated that Alzheimer's pathogeny can be endured by the brain to some measure due to compensatory mechanisms functioning at the cellular and synaptic levels said by the experts of Zain Medical Center. Researchers have also suggested that BPN14770 may be proficient in stimulating complicated physiological mechanisms. It preserve the cerebellum from memory shortfalls, neuronal impairment, and biochemical impairments.

When the drug BPN14770 was tested on mice it was found that it inhibited the action of phosphodiesterase 4D (PDE4D). It’s an enzyme that performs a pivotal character in consciousness, learning, neuroinflammation, and traumatic understanding hemorrhage. The enzyme named as PDE4D diminishes the cAMP - that has copious propitious roles, including enhanced retention. Also, cAMP acts as an intermediary particle that indicates physiological alterations. It includes cell division, transformation, movement and separation throughout the body, commencing to substantial modifications in the brain.

BPN14770 acts by an innovative mechanism to enhance cyclic AMP signalling in the brain, which has been shown to enhance memory. According to the experts of Zain Medical Center, the collaborative project has led to clinical trials that will begin to test its effectiveness.

  continue reading

13 episoder

Alle episoder

×
 
Loading …

Velkommen til Player FM!

Player FM scanner netter for høykvalitets podcaster som du kan nyte nå. Det er den beste podcastappen og fungerer på Android, iPhone og internett. Registrer deg for å synkronisere abonnement på flere enheter.

 

icon Daily Deals
icon Daily Deals
icon Daily Deals

Hurtigreferanseguide

Copyright 2024 | Sitemap | Personvern | Vilkår for bruk | | opphavsrett